HDL flux is higher in patients with nonalcoholic fatty liver disease

Altered lipid metabolism and inflammation are involved in the pathogenesis of both nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD). Even though high-density lipoprotein (HDL), a CVD protective marker, is decreased, whether HDL metabolism and function are perturbed in NAFLD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Physiol Endocrinol Metab
Autors principals: McCullough, Arthur, Previs, Stephen F., Dasarathy, Jaividhya, Lee, Kwangwon, Osme, Abdullah, Kim, Chunki, Ilchenko, Serguei, Lorkowski, Shuhui W., Smith, Jonathan D., Dasarathy, Srinivasan, Kasumov, Takhar
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6879863/
https://ncbi.nlm.nih.gov/pubmed/31503515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00193.2019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars